drugset / Trial / NCT00880243

Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

NCT00880243

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is: 1. To compare priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) during induction and consolidation courses versus no priming. 2. To compare as consolidation timed sequential chemotherapy versus four courses of high dose cytarabine.

Timeline

Start
1999-03
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject sargramostim Protein / enzyme biologic 5 ug/kg Intravenous